PIOGLITAZONE-GLIMEPIRIDE 30-2

pioglitazone and glimepiride
$10.8009per EA

Strength

2; 30 mg/1; mg/1

NDC

66993082130

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021925

On Market Since

8/4/2015

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Sulfonylurea Compounds
Sulfonylurea
Thiazolidinedione
Thiazolidinediones

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.7%

1Y

+15.2%

3Y

-4.5%

5Y

-4.5%

All

+18.8%